Quantcast
Last updated on April 16, 2014 at 4:43 EDT

Latest schizophrenia Stories

Motivation Lacking For Many Marijuana Users
2013-07-01 13:30:57

Lee Rannals for redOrbit.com - Your Universe Online Long-time marijuana smokers have a lack of motivation to work or pursue normal interests, according to a new study. Scientists at Imperial College London, University College London (UCL) and King's College London found long-term marijuana users tend to have lower levels of dopamine in a part of the brain called the striatum. They said this finding could explain why some users appear to have a lack of motivation. The team used PET...

2013-06-28 23:02:51

UNE Professor of Pharmacology Karen Houseknecht has received a four-year, $1.2 million grant from the National Institutes of Health to further study the effects of second-generation antipsychotic (SGA) medications on bone biology. These drugs are increasingly being prescribed off-label to treat a number of other ailments, including attention-deficit/hyperactivity disorder in children. Portland, Maine (PRWEB) June 28, 2013 The U.S. National Institutes of Health (NIH) reports that as...

2013-06-27 04:21:03

WELWYN GARDEN CITY, England and BOSTON, June 27, 2013 /PRNewswire/ -- Initial focus on neuroscience with first-in-class drugs for Alzheimer's disease and schizophrenia Heptares Therapeutics, the leading GPCR drug discovery and development company, today announced it has raised over US$21 million in a Series B financing to advance a clinical pipeline of novel drugs directed towards clinically validated targets for the treatment...

2013-06-25 10:59:01

Gene mutations that cause cell signaling networks to go awry during embryonic development and lead to major birth defects may also cause subtle disruptions in the brain that contribute to psychiatric disorders such as schizophrenia, autism, and bipolar disorder, according to new research by UC San Francisco scientists. Over the past several years, researchers in the laboratory of psychiatrist Benjamin Cheyette, MD, PhD, have shown that mice with mutations in a gene called Dact1 are born...

2013-06-11 23:28:50

Schizophrenia myths are prevalent in our society. As SchizLife.com celebrates its one-year anniversary, the community is working to provide accurate information about schizophrenia by creating a safe-haven for thoughtful and intelligent dialog, and debunking common but harmful myths. (PRWEB) June 11, 2013 “Living a full life with schizophrenia” is possible. This is the creed of SchizLife.com (“Schiz Life”), an online resource for schizophrenia...

2013-06-11 13:32:16

Schizophrenia, a chronic and devastating disorder characterized by the breakdown of cognition processes and typical emotional and behavioral responses, has been affecting people throughout history. Scientists believe that several genes are associated with an increased risk of schizophrenia but that no single gene causes the disease by itself. It is likely that interactions between genes and the environment are necessary for schizophrenia to develop and that epigenetic change also plays a...

Alzheimer's, Schizophrenia, and Autism Studied With Mature Brain Cells Reprogrammed From Skin Cells
2013-06-07 07:36:57

Pennsylvania State University Difficult-to-study diseases such as Alzheimer's, schizophrenia, and autism now can be probed more safely and effectively thanks to an innovative new method for obtaining mature brain cells called neurons from reprogrammed skin cells. According to Gong Chen, the Verne M. Willaman Chair in Life Sciences and professor of biology at Penn State University and the leader of the research team, "the most exciting part of this research is that it offers the promise of...

2013-05-31 08:24:14

-- OMS824 Achieves High Target Occupancy without Causing Movement Disorders Seen with Other PDE10 Inhibitors -- SEATTLE, May 31, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced positive results from its Phase 1 clinical program evaluating OMS824, the lead compound from its phosphodiesterase 10 (PDE10) program. This study measured the extent to which OMS824 binds to PDE10 in the basal ganglia, a region of the brain that has been linked to a wide range of...

2013-05-24 23:16:55

New memoir reveals a success story despite a life-changing diagnosis. EASTLEIGH, England (PRWEB) May 24, 2013 In his new memoir “Paranoid Schizophrenia: My Label, My Life” (published by AuthorHouse), author Bruce Venter opens up about his life, including the frightening and difficult events surrounding his struggle with a serious mental illness. “Paranoid Schizophrenia: My Label, My Life” traces the path of Venter´s life experiences from a happy childhood to...

2013-05-23 08:27:06

-- Clinical Trial in Patients with Huntington's Disease Slated to Begin Next Quarter -- SEATTLE, May 23, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that its Investigational New Drug Application (IND) to evaluate OMS824 in Huntington's disease has been cleared by the U.S. Food and Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an enzyme expressed in areas of the brain linked to a wide range of diseases that affect...